Disability among U.S. army personnel vaccinated against anthrax

Journal of Occupational and Environmental Medicine

Volumn 46, Issue 10, 2004, Pages 1065-1075

  Sulsky, Sandra I ^a,b   John, Grabenstein ^c   Delbos, Rachel Gross ^a,b  

^a Environ Health Sciences Institute   (United States)

^b Applied Epidemiology Inc   (United States)

^c Military Vaccine (MILVAX) Agency

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE;

ADOLESCENT; ADULT; AGED; ANTHRAX; ARMY; ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DISABILITY; FEMALE; FOLLOW UP; HUMAN; MALE; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; NONBIOLOGICAL MODEL; OCCUPATION; RISK FACTOR; SOLDIER; VACCINATION;

ADULT; AGE FACTORS; ANTHRAX; ANTHRAX VACCINES; CASE-CONTROL STUDIES; COHORT STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MILITARY PERSONNEL; PREVALENCE; REFERENCE VALUES; REGISTRIES; RISK ASSESSMENT; SEX FACTORS; UNITED STATES; VACCINATION; VETERANS DISABILITY CLAIMS;

ANTHRAX;

EID: 5444232404     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jom.0000141664.90587.47     Document Type: Article

References (15)

1. Use of anthrax vaccine in the United States. Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2000;49:1-20.
2. Demicheli V, Rivetti D, Decks JJ, et al. The effectiveness and safety of vaccines against human anthrax: a systematic review. Vaccine. 1998;16:880-884.
3. Tierney B, Martin S, Franzke L, et al. Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterroism-related inhalational anthrax. Clin Infect Dis. 2003;37:905-911.
4. Centers for Disease Control and Prevention. Surveillance for adverse events associated with anthrax vaccination - US Department of Defense, 1998-2000. MMWR Morb Mortal Wkly Rep. 2000;49:341-345.
5. Turnbull PC. Anthrax vaccines: past, present and future. Vaccine. 1991;9:533-539.
6. Pittman PR., Gibbs PH, Cannon TL, et al. Anthrax vaccine: short-term safety experience in humans. Vaccine. 2002;20:972-978.
7. Joellenbeck LM, Zwanziger LL, Durch JS, et al., eds. The Anthrax Vaccine: Is It Safe? Does It Work? Washington, DC: National Academy Press; 2002.
8. Mahan CM, Kang HK, Dalager NA, et al. Anthrax vaccination and self-reported symptoms, functional status, and medical conditions in the National Health Survey of Gulf War Era Veterans and their families. Ann Epidemiol. 2004;14:81-88.
9. Amoroso P, Swartz W, Hoin F, et al. Total Army Injury and Health Outcomes Database: Description and Capabilities, vol TN97-1, February ed. Natick, MA: US Army Research Institute of Environmental Medicine; 1997.
10. Sulsky S, Mundt KA, Bigelow C, et al. Knee-Related Injuries and Disabilities in the US Army, 1980-1997. Frederick, MD: US Army Medical Research and Materiel Command; 2000:1-155.
11. Statistical Analysis System (SAS). Cary, NC: SAS Institute; 1999.
12. STATA. College Station, TX: Stata Corp; 1984-2001.
13. Checkoway H, Pearce N, Crawford-Brown DJ. Research Methods in Occupational Epidemiology. Monographs in Epidemiology and Biostatistics, vol 13. New York: Oxford University Press; 1989.
14. May S, Hosmer DW. A simplified method of calculating an overall goodness-of-fit test for the Cox proportional hazards model. Lifetime Data Anal. 1998;4:109-120.
15. Lange JL, Lesikar SE, Rubertone MV, et al. Comprehensive systematic surveillance for adverse effects of anthrax vaccine adsorbed, US Armed Forces, 1998-2000. Vaccine. 2003;21:1620-1628.